Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
ALCON RESEARCH
🇺🇸
United States
Country
🇺🇸
United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
Phase 4 Study Comparing IOP Lowering in OAG or OH in Caucasian or Japanese Subjects C-02-32
Phase 4
Terminated
Conditions
Open-angle Glaucoma
Ocular Hypertension
Subscribe
First Posted Date
2002-10-11
Last Posted Date
2012-08-17
Lead Sponsor
Alcon Research
Target Recruit Count
84
Registration Number
NCT00047606
Subscribe
Phase 3 Study Comparing IOP Lowering in OAG or OH in Japanese Subjects C-01-98
Phase 3
Completed
Conditions
Ocular Hypertension
Open-Angle Glaucoma
Subscribe
First Posted Date
2002-10-11
Last Posted Date
2008-08-05
Lead Sponsor
Alcon Research
Registration Number
NCT00047593
Subscribe
Phase 3 Study to Evaluate Anecortave Acetate vs. Visudyne for the Treatment of the Wet Form of AMD
Phase 3
Completed
Conditions
Macular Degeneration
Interventions
Drug: Anecortave Acetate 15 mg sterile suspension
Other: Photodynamic Therapy (PDT)
Subscribe
First Posted Date
2002-08-01
Last Posted Date
2014-07-01
Lead Sponsor
Alcon Research
Target Recruit Count
530
Registration Number
NCT00041483
Locations
🇺🇸
Contact Alcon Call Center for Trial Locations, Ft. Worth, Texas, United States
Subscribe
Prev
1
57
58
59
60
61
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy